130 related articles for article (PubMed ID: 525231)
1. Clinical use of inotropic agents.
Spores J; DeWood MA
AANA J; 1979 Dec; 47(6):679-84. PubMed ID: 525231
[No Abstract] [Full Text] [Related]
2. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
3. [The old digitalis and the new cardiac inotropic agents].
Méndez R
Arch Farmacol Toxicol; 1983 Apr; 9(1):4-20. PubMed ID: 6354106
[No Abstract] [Full Text] [Related]
4. [Currently used positive inotropic substances].
Hauf GF; Grom E
Ther Umsch; 1984 Feb; 41(2):111-6. PubMed ID: 6369614
[No Abstract] [Full Text] [Related]
5. [Catecholamines in the therapy of chronic cardiac insufficiency].
Brandt D; Klein W
Wien Med Wochenschr; 1982 Oct; 132(19):450-6. PubMed ID: 6294999
[No Abstract] [Full Text] [Related]
6. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
7. Drug therapy in cardiogenic shock.
Ramdohr B
Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
[No Abstract] [Full Text] [Related]
8. [Drug therapy in cardiogenic shock].
Wenger R
Int J Clin Pharmacol; 1973 Apr; 7(2):127-31. PubMed ID: 4147221
[No Abstract] [Full Text] [Related]
9. Use of vasoactive drugs in the treatment of shock.
Berk JL
Surg Clin North Am; 1975 Jun; 55(3):721-8. PubMed ID: 1135753
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic support and the role of dopamine.
Bellomo R; Cole L; Ronco C
Kidney Int Suppl; 1998 May; 66():S71-4. PubMed ID: 9573578
[TBL] [Abstract][Full Text] [Related]
11. New developments and therapeutic applications of cardiac stimulating agents.
Williams JF
Am J Cardiol; 1973 Sep; 32(4):491-6. PubMed ID: 4580962
[No Abstract] [Full Text] [Related]
12. [Postoperative cardiac care: theoretical use of various cardiovascular agents].
Sakamoto T; Suzuki A
Rinsho Kyobu Geka; 1985; 5(2):263-70. PubMed ID: 9423013
[No Abstract] [Full Text] [Related]
13. Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
Kones RJ
Angiology; 1974 May; 25(5):317-33. PubMed ID: 4150913
[No Abstract] [Full Text] [Related]
14. Inotropic drugs in acute circulatory failure.
Herbert P; Tinker J
Intensive Care Med; 1980; 6(2):101-11. PubMed ID: 6102579
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic interventions in resuscitation.
Boike SC; Rybak MJ
Emerg Med Clin North Am; 1983 Dec; 1(3):553-69. PubMed ID: 6396072
[TBL] [Abstract][Full Text] [Related]
16. Management of shock in acute myocardial infarction.
Pema PJ
J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
[No Abstract] [Full Text] [Related]
17. Inotropic drugs for treatment of the failing heart.
Maskin CS; Le Jemtel TH; Sonnenblick EH
Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
[No Abstract] [Full Text] [Related]
18. [Protection of the ischemic myocardium].
Horwitz S; Scheidt S; Killip T
Arch Inst Cardiol Mex; 1974; 44(2):293-9. PubMed ID: 4600187
[No Abstract] [Full Text] [Related]
19. The rational selection of inotropic drugs in cardiac surgery.
DiSesa VJ
J Card Surg; 1987 Sep; 2(3):385-406. PubMed ID: 2979988
[TBL] [Abstract][Full Text] [Related]
20. Cardiogenic shock: a review.
Perlroth MG; Harrison DC
Clin Pharmacol Ther; 1969; 10(4):449-67. PubMed ID: 4893583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
